Evidence map›Paper›PMID 29687979›Full record

ArticleEnvironmental health perspectives2018

Evaluating the Association between Artificial Light-at-Night Exposure and Breast and Prostate Cancer Risk in Spain (MCC-Spain Study).

Ariadna Garcia-Saenz, Alejandro Sánchez de Miguel, Ana Espinosa, Antonia Valentin, Núria Aragonés, Javier Llorca, Pilar Amiano, Vicente Martín Sánchez, Marcela Guevara, Rocío Capelo and 14 more

Open access · diamondAbstract read
In one paragraph

Article in Environmental health perspectives, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed, 3 pooled it
12.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 3 syntheses or guidelines pooled it, 200 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Review
  6. Article
  7. Light pollution: environmental and health impacts at high latitudes.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2026
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 14 institutions in 3 countries.

Ariadna Garcia-SaenzISGlobal (Barcelona Institute for Global Health), Barcelona, Spain
Alejandro Sánchez de MiguelInstituto de Astrofísica de Andalucía (IAA)–Consejo Superior de Investigaciones Científicas (CSIC), Granada, Spain
Ana EspinosaISGlobal (Barcelona Institute for Global Health), Barcelona, Spain
Antonia ValentinISGlobal (Barcelona Institute for Global Health), Barcelona, Spain
Núria AragonésCIBER (Consorcio de Investigación Biomédica en Red) Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain
Javier LlorcaCIBER (Consorcio de Investigación Biomédica en Red) Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain
Pilar AmianoCIBER (Consorcio de Investigación Biomédica en Red) Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain
Vicente Martín SánchezCIBER (Consorcio de Investigación Biomédica en Red) Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain
Marcela GuevaraCIBER (Consorcio de Investigación Biomédica en Red) Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain
Rocío CapeloCentro de Investigación en Salud y Medio Ambiente (CYSMA), Universidad de Huelva, Huelva, Spain
Adonina TardónCIBER (Consorcio de Investigación Biomédica en Red) Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain
Rosana Peiró-PerezCIBER (Consorcio de Investigación Biomédica en Red) Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain
José Juan Jiménez-MoleónCIBER (Consorcio de Investigación Biomédica en Red) Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain
Aina Roca-BarcelóEpidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Department of Health, Autonomous Government of Catalonia, Catalan Institute of Oncology, Girona, Spain
Beatriz Pérez-GómezCIBER (Consorcio de Investigación Biomédica en Red) Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain
Trinidad Dierssen-SotosCIBER (Consorcio de Investigación Biomédica en Red) Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain
Tania Fernández-VillaCIBER (Consorcio de Investigación Biomédica en Red) Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain
Conchi Moreno-IribasInstituto de Investigación Sanitaria de Navarra (IdiSNA), Instituto de Salud Pública de Navarra, Pamplona, Spain
Victor MorenoCIBER (Consorcio de Investigación Biomédica en Red) Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain
Javier García-PérezCIBER (Consorcio de Investigación Biomédica en Red) Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain
Gemma Castaño-VinyalsISGlobal (Barcelona Institute for Global Health), Barcelona, Spain
Marina PollánCIBER (Consorcio de Investigación Biomédica en Red) Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain
Martin AubéDépartement de physique, Cégep de Sherbrooke, Sherbrooke, Canada
Manolis KogevinasISGlobal (Barcelona Institute for Global Health), Barcelona, Spain
Universitat Pompeu Fabra · ESInstituto de Salud Carlos III · ESCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública · ESInstituto de Salud Pública de Navarra · ESUniversidad de Cantabria · ESBasque Government · ESCégep de Sherbrooke · CAGeneralitat de Catalunya · ESGeneralitat Valenciana · ESInstitut d'Investigació Biomédica de Bellvitge · ESUniversidad Complutense de Madrid · ESUniversidad de Granada · ESUniversidad de Huelva · ESUniversidad de Oviedo · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNight shift work, exposure to light at night (ALAN) and circadian disruption may increase the risk of hormone-dependent cancers.

objectivesWe evaluated the association of exposure to ALAN during sleeping time with breast and prostate cancer in a population based multicase-control study (MCC-Spain), among subjects who had never worked at night. We evaluated chronotype, a characteristic that may relate to adaptation to light at night.

methodsWe enrolled 1,219 breast cancer cases, 1,385 female controls, 623 prostate cancer cases, and 879 male controls from 11 Spanish regions in 2008-2013. Indoor ALAN information was obtained through questionnaires. Outdoor ALAN was analyzed using images from the International Space Station (ISS) available for Barcelona and Madrid for 2012-2013, including data of remotely sensed upward light intensity and blue light spectrum information for each geocoded longest residence of each MCC-Spain subject.

resultsAmong Barcelona and Madrid participants with information on both indoor and outdoor ALAN, exposure to outdoor ALAN in the blue light spectrum was associated with breast cancer [adjusted odds ratio (OR) for highest vs. lowest tertile, OR=1.47; 95% CI: 1.00, 2.17] and prostate cancer (OR=2.05; 95% CI: 1.38, 3.03). In contrast, those exposed to the highest versus lowest intensity of outdoor ALAN were more likely to be controls than cases, particularly for prostate cancer. Compared with those who reported sleeping in total darkness, men who slept in "quite illuminated" bedrooms had a higher risk of prostate cancer (OR=2.79; 95% CI: 1.55, 5.04), whereas women had a slightly lower risk of breast cancer (OR=0.77; 95% CI: 0.39, 1.51).

conclusionBoth prostate and breast cancer were associated with high estimated exposure to outdoor ALAN in the blue-enriched light spectrum. https://doi.org/10.1289/EHP1837.

Indexed as

AdultAgedAged, 80 and overBreast NeoplasmsCase-Control StudiesCircadian RhythmFemaleHumansIncidenceLightLightingMaleMiddle AgedProstatic NeoplasmsRisk FactorsSpain

Identifiers

PMID29687979
PMCPMC6071739
OpenAlexW2799426468

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.